| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | NOVOCURE LTD | 1,815,479 | 21,186,000 | 26.31% | ||
| 2 | CAESARS ACQUISITION CO CL A | 1,665,032 | 18,681,000 | 23.20% | ||
| 3 | CAESARS ENTMT CORP | 1,665,032 | 12,804,000 | 15.90% | ||
| 4 | FIRST DATA CORP CL A | 790,910 | 8,755,000 | 10.87% | ||
| 5 | FITBIT INC | 456,838 | 5,582,000 | 6.93% | ||
| 6 | CDW | 93,772 | 3,975,000 | 4.94% | ||
| 7 | Fidus Investment Corp | 260,105 | 3,971,000 | 4.93% | ||
| 8 | TRANSENTERIX INC | 3,032,625 | 3,699,000 | 4.59% | ||
| 9 | QUINSTREET INC COM USD0.001 | 270,114 | 958,000 | 1.19% | ||
| 10 | ALPHATEC HOLDINGS INC | 1,344,179 | 470,000 | 0.58% | ||
| 11 | ANTERO RESOURCE CORP | 17,500 | 454,000 | 0.56% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-018927, filed 2016.08.05).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
